DARTRIAL 10 MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1037203080046 -
GGREM
542622010018004 -
Código de barras
7899420508578
O que a fonte publica
- Detentor do registro
- SUPERA FARMA LABORATÓRIOS S.A
- Princípios ativos
- RIVAROXABANA
- Embalagem
- 10 MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- B1F - INIBIDORES DIRETOS DO FATOR XA
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "DARTRIAL 10 MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 30",
"holder": "SUPERA FARMA LABORATÓRIOS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899420508578"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "542622010018004",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "43.312.503/0001-05",
"priceRegime": "Regulado",
"productName": "DARTRIAL",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "166.50",
"icms-12": "189.20",
"icms-17": "200.60",
"icms-18": "203.05",
"icms-19": "205.56",
"icms-20": "208.13",
"icms-21": "210.76",
"icms-22": "213.46",
"icms-23": "216.23",
"icms-17.5": "201.82",
"icms-19.5": "206.83",
"icms-20.5": "209.43",
"icms-22.5": "214.84",
"icms-12-alc": "186.93",
"icms-17-alc": "198.20",
"icms-18-alc": "200.61",
"icms-19-alc": "203.09",
"icms-20-alc": "205.63",
"icms-21-alc": "208.23",
"icms-22-alc": "210.90",
"icms-23-alc": "213.64",
"withoutTaxes": "164.50",
"icms-17.5-alc": "199.40",
"icms-19.5-alc": "204.35",
"icms-20.5-alc": "206.92",
"icms-22.5-alc": "212.26"
},
"pisCofinsList": "Positiva",
"substanceText": "RIVAROXABANA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "229.50",
"icms-12": "260.79",
"icms-17": "276.51",
"icms-18": "279.88",
"icms-19": "283.34",
"icms-20": "286.89",
"icms-21": "290.51",
"icms-22": "294.23",
"icms-23": "298.05",
"icms-17.5": "278.19",
"icms-19.5": "285.09",
"icms-20.5": "288.68",
"icms-22.5": "296.13",
"icms-12-alc": "258.42",
"icms-17-alc": "274.00",
"icms-18-alc": "277.33",
"icms-19-alc": "280.76",
"icms-20-alc": "284.27",
"icms-21-alc": "287.87",
"icms-22-alc": "291.56",
"icms-23-alc": "295.34",
"withoutTaxes": "227.41",
"icms-17.5-alc": "275.66",
"icms-19.5-alc": "282.50",
"icms-20.5-alc": "286.05",
"icms-22.5-alc": "293.44"
},
"invalidBarcodes": [],
"activeSubstances": [
"RIVAROXABANA"
],
"therapeuticClass": "B1F - INIBIDORES DIRETOS DO FATOR XA",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1037203080046",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "B1F",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:542622010018004"